Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Welcome to the Tessa News Link Beta! We are actively improving this experience.

Share Feedback

Source study found

Story checked

Struggling with constipation? Two green kiwifruits a day may help (opens in a new tab)

news-medical.net · 2026-11-05

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 3 supported
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Notice: Analysis is currently derived from study abstracts. Full-text paper analysis capabilities are currently in development.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Three of six claims match the study. This overall rating is based only on the claims we could check. Three claims the study doesn't address.

  • 3 supported
  • 3 not covered
Open claim evidence
3

The source study

Kiwifruit for constipation and gastrointestinal comfort: mechanisms, clinical evidence, and remaining research gaps

Food, Nutrition and Health · 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredAn international multicenter randomized crossover trial of 184 adults, including people with functional constipation, IBS-C, and healthy controls, compared two green kiwifruits daily with 7.5 g of psyllium.View evidenceHide evidence

As stated184 adults; 60 with FC, 61 with IBS-C, 63 healthy controls; 2 green kiwifruits daily vs 7.5 g psyllium

Why this verdict

The abstract-level profile does not provide this study-level detail: international multicenter randomized crossover design, 184 adults, subgroup counts, or the 7.5 g psyllium comparator. The broader existence of clinical trials and a two-kiwifruit regimen is supported, but this specific trial description is not verifiable from the supplied abstract-depth profile.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
Claim 2 of 6Not coveredDuring kiwifruit treatment, complete spontaneous bowel movements increased by 1.53 per week in functional constipation and 1.73 per week in IBS-C, with improved gastrointestinal comfort in both constipated groups.View evidenceHide evidence

As stated+1.53 CSBMs/week in FC; +1.73 CSBMs/week in IBS-C

Why this verdict

The abstract-level profile supports the general direction of increased CSBMs and improved GI comfort, but it does not provide the specific numerical increases of +1.53 and +1.73 CSBMs/week or confirm these exact subgroup results. The magnitude claim is therefore not verifiable at abstract depth.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
Claim 3 of 6Not coveredComparative trials reportedly found kiwifruit, psyllium, and prunes produced broadly similar improvements, with one U.S. trial finding no significant difference in primary responder rates and fewer adverse events and lower dissatisfaction with kiwifruit.View evidenceHide evidence

Why this verdict

The profile notes a need for comparative-effectiveness research and does not give abstract-level details on trials comparing kiwifruit with psyllium or prunes, responder-rate differences, adverse events, or dissatisfaction. General favourable tolerability is supported, but the comparative-trial specifics are not verifiable at this depth.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
2

Study evidence

Authors position kiwifruit as an evidence-based, low-burden dietary option to be used within individualised constipation care, not as a universal substitute for laxatives or dietitian-led IBS management.

“Kiwifruit is best positioned as an evidence-based, low-burden dietary option within individualised constipation care, rather than as a universal substitute for laxatives or dietitian-led IBS management.”
Claim 4 of 6SupportedA recent narrative review published in Food, Nutrition and Health evaluated the clinical evidence, mechanisms, effective dietary regimens, and potential uses of kiwifruit for functional constipation and constipation-predominant irritable bowel syndrome.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that this is a narrative review aiming to clarify clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps/practical positioning for kiwifruit in FC and IBS-C. Venue/author details are not independently evidenced in the supplied profile, but the scientific framing of the claim is supported.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
2

Study evidence

Green kiwifruit contains a combination of bulking, fermentable, and gel-forming fibre plus intrinsic water that plausibly contributes to increased stool bulk, altered stool form, and improved bowel movement frequency.

“Mechanistically, green kiwifruit combines bulking, fermentable, and gel-forming fibre properties with intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and actinidin.”
Claim 5 of 6SupportedThe review says clinical studies suggest kiwifruit improves bowel function by increasing defecation frequency, stool bulk, and softness while reducing straining.View evidenceHide evidence

Why this verdict

The profile says clinical studies synthesized in the review report increased CSBMs, improved stool form, reduced straining, and improved GI comfort. It also describes plausible fibre-related bulking mechanisms. The wording is hedged as 'suggest,' so it does not overstate the abstract-level evidence.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
2

Study evidence

Green kiwifruit contains a combination of bulking, fermentable, and gel-forming fibre plus intrinsic water that plausibly contributes to increased stool bulk, altered stool form, and improved bowel movement frequency.

“Mechanistically, green kiwifruit combines bulking, fermentable, and gel-forming fibre properties with intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and actinidin.”
Claim 6 of 6SupportedThe review concludes that consuming two fresh green kiwifruits daily for about four weeks is a potential dietary strategy for adults with functional constipation or IBS-C, while noting limits and that evidence is strongest for fresh green kiwifruit rather than gold varieties, powders, or extracts.View evidenceHide evidence

As statedtwo fresh green kiwifruits daily for approximately four weeks

Why this verdict

The profile states that the strongest evidence supports two fresh green kiwifruits daily for approximately 4 weeks in adults with FC, IBS-C, or chronic constipation and frames kiwifruit as a low-burden dietary option within individualized care. It also emphasizes green kiwifruit and cultivar-specific gaps. The clauses about powders/extracts are more specific than the abstract profile, but the main claim is supported.

1

Study evidence

The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.

“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
2

Study evidence

Green kiwifruit contains a combination of bulking, fermentable, and gel-forming fibre plus intrinsic water that plausibly contributes to increased stool bulk, altered stool form, and improved bowel movement frequency.

“Mechanistically, green kiwifruit combines bulking, fermentable, and gel-forming fibre properties with intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and actinidin.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The authors position kiwifruit as an evidence-based, low-burden option within individualized constipation care, not as a universal substitute for laxatives or dietitian-led IBS management.

    The story uses cautious language such as 'potential dietary strategy' and includes advice to seek medical assessment for alarm symptoms, but the specific limitation that kiwifruit should not be treated as a universal laxative substitute or replacement for dietitian-led IBS care is not clearly reflected.

    From Narrative review gap analysis / expert conclusion framing

6 things the story did carry across
  • The paper is a narrative review synthesizing evidence from 33 included publications identified through PubMed and Web of Science searches.
  • The strongest evidence identified by the review supports two fresh green kiwifruits daily for approximately 4 weeks in adults with FC, IBS-C, or chronic constipation.
  • Clinical outcomes summarized in the review include increased complete spontaneous bowel movements, improved stool form, reduced straining, improved GI comfort, and generally favourable tolerability.
  • The review presents plausible mechanisms for green kiwifruit, including fibre properties, water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and actinidin.
  • The paper identifies research gaps including cultivar-specific effects, long-term adherence, clinically meaningful effect sizes, and comparative effectiveness.
  • Important abstract-level limitations include narrative rather than meta-analytic synthesis, English-language restriction, no pooled quantitative effect sizes in the abstract, and lack of abstract-level study-design/sample/risk-of-bias details.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataSynthesize and clarify the clinical evidence for kiwifruit as a dietary intervention for functional constipation (FC), IBS-C, and related GI discomfort, including effective regimens and outcomes.Narrative reviewExpand

In plain English

Narrative review synthesizing clinical trial and human-intervention evidence (n=33 included studies) on kiwifruit for functional constipation (FC), constipation-predominant IBS (IBS-C), chronic constipation, and related gastrointestinal (GI) comfort. The authors conclude the strongest clinical evidence supports consumption of two fresh green kiwifruits daily for about 4 weeks in adults, reporting increases in complete spontaneous bowel movements (CSBMs), improved stool form, reduced straining, and improved GI comfort with generally favourable tolerability. Mechanistic rationale for green kiwifruit includes combined bulking, fermentable, and gel-forming fibre properties plus intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and the protease actinidin. The review frames kiwifruit as an evidence-based, low-burden dietary option within individualized constipation care and highlights remaining research gaps (cultivar-specific effects, long-term adherence, clinically meaningful effect sizes, and comparative effectiveness).

Key findings

  • The review identifies the strongest clinical evidence for using two fresh green kiwifruits daily for approximately 4 weeks in adults with functional constipation, IBS-C, or chronic constipation.
  • Clinical studies synthesized report increases in complete spontaneous bowel movements (CSBMs).
“This narrative review aimed to clarify the clinical evidence, plausible mechanisms, effective regimens, and remaining research gaps”
What this piece can’t prove
  • Narrative review format reported (abstract does not state that a systematic review or meta-analysis was performed).
  • Search limited to English-language publications.

2 further details could not be confirmed from the summary.

2secondary dataIntegrate and explain plausible mechanisms (e.g., fibre properties, water, sorbitol, polyphenols, actinidin, microbiota-active substrates) by which green kiwifruit may improve constipation and GI comfort, including cultivar-specific considerations.Narrative mechanistic reviewExpand

In plain English

Narrative mechanistic synthesis (secondary literature integration) proposes that green kiwifruit may improve bowel function and gastrointestinal comfort via combined bulking, fermentable, and gel-forming fibre properties together with intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and the protease actinidin. The mechanisms are presented as plausible, cultivar-framed explanations integrated with recent clinical trial evidence rather than as new experimental demonstration.

Key findings

  • Green kiwifruit contains a combination of bulking, fermentable, and gel-forming fibre plus intrinsic water that plausibly contributes to increased stool bulk, altered stool form, and improved bowel movement frequency.
  • Non-fibre constituents—sorbitol, polyphenols, microbiota-active substrates, micronutrients, and the protease actinidin—are hypothesized to contribute to GI comfort and bowel function via osmotic effects, modulation of gut microbiota/metabolism, mucosal interactions, and proteolytic activity.
“Mechanistically, green kiwifruit combines bulking, fermentable, and gel-forming fibre properties with intrinsic water, sorbitol, polyphenols, microbiota-active substrates, micronutrients, and actinidin.”
What this piece can’t prove
  • Mechanisms are presented as plausible, interpretive syntheses rather than as experimentally proven causal pathways.
  • Narrative review approach limits the ability to quantify effect sizes or to perform formal synthesis of mechanistic evidence strength.
  • Cultivar heterogeneity and lack of detailed component-level trials mean relative contributions of individual constituents remain uncertain.
  • Long-term adherence, clinically meaningful effect thresholds, and comparative effectiveness versus other interventions are not addressed mechanistically in the review abstract.
3otherIdentify remaining research gaps and practical positioning of kiwifruit within constipation/IBS-C care (e.g., not a universal laxative substitute; needs for comparative effectiveness, long-term adherence, cultivar-specific effects).Narrative review gap analysis / expert conclusion framingExpand

In plain English

The authors conclude that, based on a narrative synthesis of 33 publications, kiwifruit is best framed as an evidence-based, low-burden dietary option to include within individualised care for adults with functional constipation or IBS-C rather than as a universal substitute for laxatives or dietitian-led management. They identify remaining research gaps and call for randomized and comparative trials (and other studies) to define cultivar-specific effects, long-term adherence, clinically meaningful effect sizes, and comparative effectiveness versus other treatments.

Key findings

  • Authors position kiwifruit as an evidence-based, low-burden dietary option to be used within individualised constipation care, not as a universal substitute for laxatives or dietitian-led IBS management.
  • Authors recommend that further trials should define cultivar-specific effects (e.g., green vs. gold kiwifruit), long-term adherence, clinically meaningful effect sizes, and comparative effectiveness against other constipation therapies.
“Kiwifruit is best positioned as an evidence-based, low-burden dietary option within individualised constipation care, rather than as a universal substitute for laxatives or dietitian-led IBS management.”
What this piece can’t prove
  • The appraisal-unit content reports author recommendations and identified research gaps rather than presenting new primary empirical data or systematic review meta-analysis results within this unit.
  • Long-term effects, adherence, and comparative-effectiveness data are noted as lacking and thus limit definitive practice-change recommendations.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Kiwifruit for constipation and gastrointestinal comfort: mechanisms, clinical evidence, and remaining research gaps

Food, Nutrition and Health · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 16 candidate papers

Selected

Kiwifruit for constipation and gastrointestinal comfort: mechanisms, clinical evidence, and remaining research gaps

Food, Nutrition and Health · 2026 · Crossref

Source (opens in a new tab)
Candidate

Tu1644 - Green Kiwifruit Compared to Psyllium for the Relief of Constipation and Improving Digestive Comfort in Patients with Functional Constipation and Constipation Predominant Irritable Bowel Syndrome — Analysis of Three International Trial Centres

Gastroenterology · 2018 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.